Oruka Therapeutics, Inc. ORKA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$31.82M-7.6% | -$29.58M+2.3% | -$30.28M-23.2% | -$24.57M-17.0% | -$21M+74.9% | ||
| $43K+53.6% | $28K+40.0% | $20K+5.3% | $19K+18.8% | $16K-40.7% | ||
| $6.97M+69.3% | $4.12M-59.5% | $10.17M+100% | $5.08M+4.0% | $4.88M-67.3% | ||
| -$23.58M-4.4% | -$22.59M-4.6% | -$21.6M+6.7% | -$23.15M-10.9% | -$20.87M+63.9% | ||
| $73K+15.9% | $63K-36.4% | $99K+191% | $34K+162% | $13K-93.1% | ||
| -$14.44M+34.4% | -$22.02M+82.0% | -$122.45M-2,620% | $4.86M-88.7% | $42.87M+113% | ||
| $40.6M+13,524% | $298K-99.8% | $169.91M— | —— | —— | ||
| $2.59M+106% | -$44.32M-271% | $25.86M+242% | -$18.18M-183% | $22M-64.3% | ||
| -$23.65M-4.4% | -$22.66M-4.4% | -$21.7M+6.4% | -$23.18M-11.0% | -$20.88M+64.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Oruka Therapeutics, Inc. generate?
- Oruka Therapeutics, Inc. (ORKA) generated -$90.9M in operating cash flow over the trailing twelve months.
- What is Oruka Therapeutics, Inc.'s free cash flow?
- After $269.0K of capital expenditures, Oruka Therapeutics, Inc.'s free cash flow was -$91.2M over the trailing twelve months, up 23.6% year over year.
- Where does Oruka Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Oruka Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.